Form 4: SANUWAVE Insiders Sell Shares in December 2025

Multiple reporting persons associated with SANUWAVE Health, Inc. disclosed sales of common stock totaling 144,810 shares in early December 2025.

Summary

• Manchester Explorer, L.P. sold 125,400 shares of SANUWAVE Health, Inc. common stock on December 8, 2025, at a price of $30.75 per share.
• Manchester Explorer, L.P. sold an additional 8,785 shares on December 9, 2025, at a weighted average price of $30.5838 per share.
• Manchester Explorer, L.P. sold another 8,625 shares on December 10, 2025, at a weighted average price of $30.3918 per share.
• James E. Besser, a director, sold 2,000 shares of common stock on December 8, 2025, at a weighted average price of $31.6017 per share.
• Following these transactions, Manchester Explorer, L.P. indirectly beneficially owns 863,980 shares.
• James E. Besser directly beneficially owns 2,000 shares in his personal capacity.
• JEB Partners, L.P. indirectly beneficially owns 83,999 shares.
• Morgan C. Frank directly beneficially owns 52,653 shares and warrants.

Sentiment

Score: 3

Explanation: The sentiment is negative due to significant insider selling by multiple reporting persons, including a 10% owner and a director, which often signals a lack of confidence in the near-term stock performance.

Negatives

• Multiple insiders, including entities associated with a 10% owner and a director, sold a significant number of shares (144,810 shares in total) over three consecutive days.
• The sales occurred at prices ranging from $30.00 to $33.50, indicating a decision to divest at these levels.

Future Outlook

No future outlook or guidance is provided in this filing.

Industry Context

This filing is specific to insider transactions and does not provide broader industry context or trends.

Related Party Transactions

• Sales of common stock by Manchester Explorer, L.P., which is indirectly beneficially owned by Manchester Management Co LLC, Manchester Management PR, LLC, James E. Besser (managing member), and Morgan Frank (portfolio manager/consultant).
• Sale of common stock by James E. Besser in his personal capacity.

Stakeholder Impact

• Shareholders: The selling activity by significant shareholders and a director could be perceived negatively, potentially leading to downward pressure on the stock price due to concerns about insider confidence.

Key Dates

Recommendation

The significant insider selling by multiple reporting persons, including a 10% owner and a director, suggests a lack of confidence in the company's near-term prospects or a belief that the stock is currently overvalued. Such a pattern of selling by those with intimate knowledge of the company often precedes periods of underperformance, warranting a 'sell' recommendation for investors.

Keywords

SANUWAVE Health, SNWV, Insider Selling, Form 4, Stock Sale, Beneficial Ownership, Manchester Management, James E. Besser, Morgan C. Frank